Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Stone Paper® Partners With Health Industry Leaders in Mask Production Around the World


News Image

We offer an alternative material which satisfies all the characteristics of a paper, while at the same time providing the competencies of plastic, without their structural limitations or drawbacks.

Around the world, people have been using combinations of fabric, paper, and plastic shields over their faces to avoid contagion. In an effort to do its part to fight the novel COVID-19 virus, Stone Paper®, a mineral paper producer based in B.C. Canada, is offering a durable and eco-friendly material to create masks without plastic or paper.

“We offer an alternative material which satisfies all the characteristics of a paper, while at the same time providing the competencies of plastic, without their structural limitations or drawbacks. Essentially the best of both worlds,” says Sam Farhangi, Chairman and CEO of Stone Paper®.

The material Mr. Farhangi speaks of is naturally impermeable, which satisfies the most important need for the production of masks. Stone Paper® is less expensive, causes a smaller environmental footprint by saving water and energy, and requires less treatment to reduce flammability. Masks made with this material carry the added benefits of being waterproof, washable, anti-bacterial, fire retardant, anti-grease, as well as having no use of trees, water, bleach or any hazardous chemicals in the production process.

The mineral paper has Cradle-2-Cradle certification and is compliant with health regulations. It is currently used as disposable medical examination bed sheets due to its anti-bacterial and antimicrobial, non-stick and non-combustibility (fire retardant) properties. Using a custom-made material from their mineral paper substrate, the company intends to produce N95 masks as well as procedural and surgical masks.

Share article on social media or email:

ChaseData Donates Call Center Software to Florida Health Departments


“ChaseData’s system has proven effective, stable and efficient and has been in operation for over 20 years,” says Ahmed Macklai

“As this emergency progresses, we want to help Florida counties manage the messaging and distribution of critical information using ChaseData’s automated voice and telephone technologies,” says Ahmed Macklai, founder and CEO of ChaseData Corp. “ChaseData’s system has proven effective, stable and efficient and has been in operation for over 20 years.”

ChaseData is donating high-efficiency automated contact functions like voicemail drops and SMS, as well as incoming and outgoing helpline telephone numbers for public health departments for each Florida county and the State Health Department Headquarters. This donation is open to all of Florida’s 67 counties and is being used to boost the distribution of accurate information during the COVID-19 pandemic.

According to research, people ages 60 and older — the age group most at risk of infection — are best reached by telephone, so ChaseData’s systems will help Florida health departments reach those residents through automated voice and phone technologies. Florida counties plan on using automated and personalized voicemail messages, as well as caller ID and existing data in the health departments’ databases, to deliver geographically relevant information in real-time.

County health department call centers can be decentralized and operated remotely, meaning agents and managers can safely work from home during the COVID-19 outbreak. Users can access ChaseData’s secure agent and admin applications, allowing call center agents and managers to manage telephone calls from home.

About ChaseData Corp

CEO Ahmed Macklai founded ChaseData Corp back in 1996 in Plantation, Florida as a way to offer cloud-based call center technology to companies struggling with their current call center setup or inefficient software. ChaseData provides innovative solutions to businesses, including the very first web-based business-to-business (B2B) and business-to-consumer (B2C) platform in the world. This platform helps businesses improve their customer satisfaction by making calls more quickly and efficiently, make better business decisions with industry-specific data and solutions, increase the productivity and efficiency of call center associates by tracking what agents are doing with their phone time and decrease overall operations costs. Today, ChaseData has a cloud network with more than 5,000 daily users and leads the market in affordable technology solutions that are accessible to all companies, not just enterprise.

Learn more by visit ChaseData’s website here: https://www.chasedatacorp.com/

Share article on social media or email:

American College of Healthcare Trustees and Untethered Labs’ GateKeeper Enterprise Partner to Offer Healthcare Organizations Fastest Hands-Free Computer Access Control


GateKeeper enhances corporate compliance and cyber security through mass automated wireless authentication, protecting networks from internal breaches and confidential data exposure.

“We are proud to partner with an industry leader to help ACHT members and other healthcare organizations proactively address security vulnerabilities & HIPAA compliance without disrupting their workflow.” Irma Rastegayeva, SVP Marketing & Strategic Engagement

The American College of Healthcare Trustees (ACHT) and Untethered Lab’s GateKeeper Enterprise, an on-premise identity access management platform, announce partnership to help hospitals, physician practices and other healthcare organizations to enhance productivity through touchless authentication, while also avoiding unnecessary HIPAA fines and data breaches. This partnership is further supported by ACHT Fellow Craig Petronella and Petronella Technology Group (PTG), experts in HIPAA compliance.

“During these unprecedented times, when there are increased pressures on the healthcare sector, we are proud to partner with an industry leader to help ACHT members and other healthcare organizations proactively address security vulnerabilities without disrupting their workflow,“ said Irma Rastegayeva, ACHT’s SVP of Marketing & Strategic Engagement. “With touchless access management, healthcare providers can focus on patients, while avoiding unnecessary fines due to lack of HIPAA compliance.”

ACHT fellow and friends can use GateKeeper Enterprise to ensure all unattended computers are secured with zero interaction. Gatekeeper is different from other authentication providers because its unique patented proximity auto-lock feature is designed to fit within your existing workflow. In a single dashboard, IT teams and administrators can manage all staff logins to protect sensitive data.

ACHT, GateKeeper and PTG will be holding a special free Cybersecurity webinar on May 27th at 12pm ET. All webinar attendees will be offered a chance to win one of three (3) 45-day GateKeeper Enterprise Trials (valued at $435 each).

Date: Wednesday, 5/27/2020, 12:00 PM ET.

Webinar registration: https://facht.org/content.aspx?page_id=4002&club_id=666713&item_id=1208302

ACHT fellows and friends who are interested in deploying GateKeeper Enterprise auto-lock authentication solution, please contact Dr. Levien at david.levien@facht.org or (844) 322-4867.

You can also contact Felton Lewis IV, VP of Alliances and Member Benefits, ACHT at or felton.lewis4@facht.org (844) 322-4867 ext 703.

About ACHT

The American College of Healthcare Trustees (ACHT) is a national professional association dedicated to promoting high performing, competent, qualified, ethical governance and leadership in healthcare that is person-centered and accountable by providing continuing education, resources, and networking.

Become a Fellow of the American College of Healthcare Trustees now: https://bit.ly/joinACHT.

About Untethered Labs

Untethered Labs, Inc. is the leader in proximity enterprise identity and access management technology, servicing enterprise security and 2FA needs. We provide automated privileged access management solutions for a wide range of industries including healthcare, MSP/MSSPs, law enforcement, manufacturing, and finance. Our patented technology increases security and reduces support costs with touchless, proximity-based two-factor computer authentication, centralized enterprise password management, and auditing. With partners worldwide, we are able to effectively deploy GateKeeper in nearly any environment. Created by specialists in semiconductor technologies and electronic design. Hundreds of corporations in the U.S. and around the globe rely on GateKeeper every second to secure their internal networks, prevent data breaches, and continuously authenticate users. Call 240-547-5446 or contact us for more information.

Share article on social media or email:

Anti3 Takes Precautions To Disinfect and Clean Surfaces Heading Back To Work


Overall, there are protective measures that should be taken in order to continue to stop the spread of Covid-19, especially when everyone goes back to work, quote CEO Dean Spinato

As some American businesses begin to reopen, it is vital that the Anti3 take precautions to disinfect and clean surfaces and equipment to continue to prevent the spread of Coronavirus. Whether customers work in an office, a gym, from home or any other facility there are ways to effectively kill viruses and bacteria.

Use EPA Registered disinfectants such as Anti3 Protect Series to clean surfaces and equipment:

It is important to use disinfectants that are deemed effective by the CDC. One way to tell that a product is effective is by determining whether they are EPA Registered or now. Anti3 Protect Series products are EPA Registered, which means they are proved to kill 99.9% of viruses and bacteria.

Clean surfaces and equipment that people come into contact with often and thoroughly:

If you work in an office, surfaces such as desks, chairs and door handles are high-traffic areas for germs and bacteria to spread. In gyms, workout equipment can become hotspots for bacteria due to sweat. At home, particularly if you have someone that is going out often, your couches, floors and other surfaces can become contaminated as well. Using Anti3 Disinfecting Spray is a simple way to rid these areas of virus-causing bacteria. Simply spray the formula on the surface of the item you wish to disinfect and let it air-dry.

Disinfect shoes:

Your shoes are one of the main culprits in picking up germs and bringing them to other locations such as your home or public places. It is important to disinfect your shoes after you wear them out to prevent them from spreading bacteria to other places. Spray your shoes inside and out, particularly the bottom, with Anti3 Protect Series Disinfecting Spray and let air-dry to eliminate 99.9% of bacteria and viruses.

Wash hands often:

It is essential that all of us continue to wash our hands often and effectively. Wash hands wish soap for 20-seconds or the length of singing “Happy Birthday” twice. Do this whenever you think you may have been exposed to bacteria or germs. When you don’t have access to soap, substitute hand sanitizer instead.

Maintain social distance:

Even when everyone begins to go back to work, it is important that that everyone continues to maintain social distance from others as much as possible.

“Overall, there are protective measures that should be taken in order to continue to stop the spread of Covid-19, especially when everyone goes back to work, quote CEO Dean Spinato”

To learn more about Anti3 Protect Series:

EPA CERTIFIED EFFECTIVE AGAINST COVID-19 CORONAVIRUS, Plus Staph, MRSA, Influenza A, SARS and Norovirus.

Anti3 Protect Series was formulated to be the ultimate protection against a wide spectrum of virulent microorganisms, including COVID-19 Coronavirus, MRSA, Influenza A, SARS and Norovirus. It comes in a convenient spray for all home and office surfaces and equipment, as well as a concentrate disinfectant for large areas, floors and facilities.

Share article on social media or email:

Houston Medical Malpractice Lawyers Reject Coronavirus Lawsuits


Given the unprecedented circumstances surrounding COVID-19, we believe that, under the circumstances, assuming good-faith efforts to treat, that we can neither prove a breach of the standard of care nor causation.

To honor and support the heroes of the healthcare system in Texas, Houston medical malpractice lawyers have announced that they will not accept COVID-19 cases that seek to sue doctors, hospitals or nursing homes for their good-faith efforts in treating COVID-19 patients. Houston-based law firms Brown, Christie & Green and McGehee, Chang, Landgraf, Feiler have announced that they will not pursue coronavirus lawsuits in these circumstances.

In their coronavirus lawsuit announcement, Brown, Christie & Green managing partner, Charles Brown, says,

“Given the unprecedented circumstances surrounding COVID-19, we believe that, under the circumstances, assuming good-faith efforts to treat, that we can neither prove a breach of the standard of care nor causation. We do not believe that there is a true standard of care in light of the uniqueness of this situation.”

In a similar announcement, McGehee, Chang, Landgraf, Feiler says,

“We know that hospitals are doing their best to write new policies, try new protocols and manage the pandemic. As they develop responses, mistakes will be made. Some mistakes will hurt people. Some mistakes will look obvious in retrospect. This problem is unprecedented until we find a solution.”

While they will not accept these coronavirus lawsuit cases, these plaintiff’s law firms will continue to offer legal guidance and services to families impacted by healthcare negligence. Their attorneys handle cases involving medical malpractice, nursing home abuse, birth injuries, wrongful death, sepsis and VA claims.

About Brown, Christie & Green

Brown, Christie & Green is a litigation boutique that focuses on medical malpractice and healthcare litigation. The attorneys at Brown, Christie & Green are experienced in handling medical malpractice cases, including nursing home abuse, brain injury, medical errors, and more. The law firm’s primary office is located in Houston, Texas, with additional offices in Dallas, Austin, San Antonio and Brownsville.

To contact Brown, Christie & Green, call 1-800-600-4210, or visit their website at https://www.medmalfirm.com/.

About McGehee, Chang, Landgraf, Feiler

McGehee, Chang, Landgraf, Feiler represents individuals who are harmed by the misconduct of others. The attorneys at McGehee, Chang, Landgraf, Feiler are experienced business, medical and litigation professionals. Their team handles cases involving injured children, medical malpractice, personal injury and wrongful death.

To contact McGehee, Chang, Landgraf, Feiler, call 1-713-864-4000, or visit their website at https://lawtx.com/.

Share article on social media or email:

New Research Shows Effectiveness of Hearing Voices Groups


photo of gail hornstein at her desk

Research psychologist & author Gail Hornstein, PhD

To have allies who get in that foxhole with you and try to figure out strategies when things are going bad…I’ve waited all my life for something like that.

In an article published in the journal Psychosis, Gail Hornstein, PhD, Mount Holyoke College Professor Emerita of Psychology (and her co-authors Emily Robinson Putnam and Alison Branitsky), present the first set of results from their national study of Hearing Voices Groups (HVGs). Their project is the largest and most in-depth examination of such groups ever conducted, and the first to be based in the US. HVGs offer an alternative to traditional mental health interventions focused on stopping or trying to block experiences classified as “hallucinations.” Although these groups have spread to 30 countries on five continents and are rapidly expanding across the US, few studies have analyzed their effectiveness.

The researchers recruited a diverse sample of 113 HVG members from across the US, who completed detailed questionnaires and interviews about whether and how their lives have changed since participating in the group. Results indicated that the egalitarian and non-prescriptive nature of these groups, where support is mutual and power is shared, as well as the openness to a multiplicity of understandings and strategies regarding voice hearing, were crucial to reducing distress and enabling more effective coping. As one participant said, “To have allies who get in that foxhole with you and try to figure out strategies when things are going bad is just invaluable . . . I’ve waited all my life for something like that.” Although the researchers found that no one outcome is sought by all HVG members, thus precluding any single measure of group effectiveness, 79% of participants in this study reported experiencing helpful changes in their voices, their interpersonal relationships, and/or how they understood their voices as a result of attending the group. As one member put it, “I can feel and act more like a person and less like a problem.” Many participants were able to return to work or school, get off disability, and make less use of hospital or crisis services. The availability of both in-person and online groups added flexibility and increased access.

“Our findings significantly strengthen the evidence base for the Hearing Voices approach,” said Dr. Hornstein. “Mental health professionals often wonder whether these groups work, and if so, how. Our 3-phase model explains how the unique elements that distinguish HVGs from other kinds of clinical or support groups work together to enable significant transformation to occur.”

The paper highlights the importance of including people with lived experience as key members of the team in studies like this. “Given the long and distressing history of psychiatric patients being recruited for research studies without their consent or for purposes not fully disclosed to them, we see our intentional inclusion of voice hearers on the team at every stage of the project as an important corrective and encourage other researchers to move toward this goal in their own work,” the authors note.

They emphasize that HVGs can be integrated into traditional mental health settings, at a significant cost savings to providers and insurers as compared with more expensive and less effective approaches currently in widespread use. “We hope this research will encourage adoption of HVGs in a variety of healthcare and social services,” Dr. Hornstein said. “We are way behind the UK and Europe in making this powerful alternative available across the US.”

The research was made possible by a grant from Open Excellence. The mission of Open Excellence is to connect the passion of private philanthropy with the world’s top researchers and innovation to bring recovery–based care and supports to every community. Dr. Hornstein is the advisor to Open Excellence’s Hearing Voices Research and Development Fund.

Contact: Gail A. Hornstein, PhD

ghornste@mtholyoke.edu

Share article on social media or email:

NeoTract Designates Dr. Marina Cheng as UroLift® Center of Excellence


News Image

“Dr. Marina Cheng has earned the UroLift Center of Excellence designation for her dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Marina Cheng M.D., Providence Urology in Olympia, WA, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Cheng has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“Dr. Marina Cheng has earned the UroLift Center of Excellence designation for her dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit.

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

For Teleflex Incorporated:

Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504 nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

The Professional Protector Plan® for Dentists Promotes Industry Professional Cornelius Briscoe to the Director of Claims


News Image

The Professional Protector Plan® for Dentists (PPP), a division of Protector Plans, is pleased to announce the promotion of Cornelius Briscoe, an industry professional with 20+ years of experience in handling dental malpractice claims, to the Director of Claims. In his new role, Briscoe will report to Laura Simon, the Protector Plans’ Executive Vice President responsible for Claims Services.

Briscoe joined the dental claims team in 2017 and brought a 21-year career devoted to insurance claim handling with a concentration in professional liability and commercial general liability claims. Briscoe has extensive experience in handling medical malpractice claims, with fourteen (14) years devoted primarily to dental malpractice, including large Dental Service Organizations. Briscoe is also a U.S. Navy Veteran, where he served for twelve (12) years. He holds the Casualty Claims Law Associate (CCLA), Fraud Claims Law Associate (FCLA) and Senior Claim Law Associate (SCLA) designations. He received his undergraduate degree in Business Management and his Masters of Business Administration from the University of Phoenix.

“My goal as Director of the Dental Claims Program is to support the Dental Program’s growth by delivering unmatched claims service to our agents and customers,” said Briscoe. “We will continue to work closely with our internal and external business partners to provide superior customer service and ensure that their claims needs are met on a daily basis.”

“Cornelius has proven himself to be an outstanding claims professional and consummate team player, “ said Simon. “The Dental Claims Team will thrive under his leadership, and our business partners will benefit greatly from the depth of his experience and industry insights.”    

The PPP has been insuring dentists and dental practices for more than 50 years by offering a complete package policy including professional liability, general liability, employment practices liability and property coverage—a unique grouping of coverages that is unmatched in the U.S. marketplace. The foundation of the PPP was based on the philosophy that dentists should not only have complete insurance protection, but they should also have the tools necessary to minimize exposures to claims and unexpected dental incidents.

A trailblazer in the dental market since 1969, the program includes comprehensive insurance solutions, risk management benefits and claims services. Proven to be a recognized leader within the industry, 19 state and local Dental Associations across the country currently recommend the PPP. The program is offered by exclusive agents across the U.S. who specialize in dental malpractice insurance with an average tenure of 21 years with the PPP program.

About Professional Protector Plan for Dentists®

Through their network of specialized agents, the PPP has been serving dentists nationwide since 1969. This comprehensive insurance program was developed specifically for the dental practice. The plan is offered in all 50 states plus Puerto Rico and the Virgin Islands and insures approximately 30,000 dentists nationwide.

The Professional Protector Plan for Dentists® is a division of Protector Plans (B&B Protector Plans), a wholly-owned subsidiary of Brown & Brown, Inc. For more information on the insurance products for dentists and risk management services the PPP has to offer, visit our website at http://www.protectorplan.com.

Brown & Brown, Inc. (NYSE: BRO) is a leading insurance brokerage firm, providing risk management solutions to individuals and businesses. With more than 80 years of proven success and thousands of teammates, we offer knowledge you can trust and strive to deliver superior customer service. For more information, please visit bbinsurance.com.

Share article on social media or email:

Roswell Park to Assess Immunotherapy Combination in Cancer Patients With COVID-19


We believe that the two agents to be tested in our trial, given together, can activate the missing interferon response in COVID-19-infected cells.

A unique two-drug immunotherapy combination first evaluated at Roswell Park Comprehensive Cancer Center as an approach for treating some cancers will soon be available to cancer patients with COVID-19 through a clinical trial at Roswell Park. The U.S. Food and Drug Administration has authorized clinical researchers at the center to conduct a study assessing the safety and effectiveness of giving both rintatolimod and interferon alfa to cancer patients with COVID-19, the disease caused by the novel coronavirus. The study is one of very few worldwide to repurpose an experimental cancer therapy as treatment for COVID-19.

“This is exciting and noteworthy science,” says Roswell Park President and CEO Candace S. Johnson, PhD. “It’s a rare example of a concept for COVID-19 therapy that emerged from academic researchers rather than a pharmaceutical company, and it was a Roswell Park team that looked at the way these two drugs work and saw a possibility for them to enhance each other’s effects — first against cancer and now as a possible treatment for COVID-19.”

Pawel Kalinski, MD, PhD, Vice Chair for Translational Research at Roswell Park, was the first researcher to propose giving these two immune-modulating drugs in combination as treatment for cancer, and is scientific lead on five clinical studies in progress or in development assessing the combination in patients with solid-tumor cancers including breast and colorectal cancer. He and clinical principal investigator Brahm Segal, MD, will lead the team investigating whether the two drugs may function effectively together as antiviral agents that could benefit patients with COVID-19.

“There are similarities between cancer and COVID-19, which both manage to avoid activating the interferon pathway,” says Dr. Kalinski, who is also Director of Cancer Vaccine and Dendritic Cell Therapies, Rustum Family Professor for Molecular Therapeutics and Translational Research and Professor of Oncology at Roswell Park, and will be scientific lead on the study. “This helps them to go undetected and spread in patients’ bodies, and differentiates them from viruses that cause the common cold, which cause rapid symptoms and are rapidly cleared by the immune system.”

“We believe that the two agents to be tested in our trial, given together, can activate the missing interferon response in COVID-19-infected cells,” he adds. “This would induce protective interferons and other antiviral factors in adjacent cells, stopping the virus from spreading in patients’ bodies and generating a synergistic effect that could help cancer patients with mild or moderate COVID-19 to fight the virus before it causes serious damage to the lungs or other organs.”

“SARS coronaviruses such as SARS-CoV-2, the virus that causes COVID-19, take hold because they’re able to evade the innate immune system,” notes Dr. Segal, who is Chair of Internal Medicine and Chief of Infectious Diseases at Roswell Park and Professor at both Roswell Park and the University at Buffalo. “The premise for the trial is that by activating the interferon pathway with these two agents, we may be able to deprive the virus of the ability to replicate, knocking it out before it has a chance to cause severe lung damage or other serious effects. Promising results would pave the way to a larger clinical trial that would include non-cancer patients at high risk for COVID-19 complications.”

Patients with cancer and COVID-19 have a risk of severe illness up to five times higher than people without cancer, underscoring the importance of work to develop new treatment options.

Interferon alfa-2b, also known as interferon A (made by various manufacturers), is an FDA-approved drug that has been used in the treatment of some cancers and can boost antiviral immunity. Rintatolimod (brand name Ampligen, manufactured by AIM ImmunoTech Inc.), a form of double-stranded RNA that mimics viral RNA, is an investigational agent that can be recognized by our immune system and activates antiviral defense pathways.

The new clinical trial will test the safety of this combination regimen in patients with cancer and mild to moderate COVID-19, and the extent to which this therapy will promote clearance of the SARS-CoV-2 virus from the upper airway. Earlier published research from Dr. Kalinski’s lab has demonstrated that the combination of rintatolimod and interferon alfa-2b shows synergistic activity in preclinical cancer treatment models.

The phase 1/2b study will enroll approximately 40 patients in two stages. Phase 1 will see 12-24 patients receiving both rintatolimod and interferon alfa-2b at escalating doses. Once that initial phase is complete, further study participants will be randomized to two arms, or groups: one receiving the two-drug combination and a control group who will not receive rintatolimod or interferon alfa but will receive best available care.

AIM ImmunoTech has agreed to provide rintatolimod (Ampligen) at no charge for this study.

Additional clinical sites for the study may be added. The new study in cancer patients with COVID-19 will not investigate the effectiveness of this approach as a treatment for cancer; separate studies of that nature are underway at Roswell Park.

Funds donated to Roswell Park’s COVID-19 Response Fund can be earmarked to support this effort. Please read more here or go to give.roswellpark.org/COVID-19.

###

This news release is also available on the Roswell Park website: https://www.roswellpark.org/newsroom/202005-roswell-park-assess-immunotherapy-combination-cancer-patients-covid-19

Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer’s grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at http://www.roswellpark.org, or contact us at 1-800-ROSWELL (1-800-767-9355) or ASKRoswell@RoswellPark.org.

Share article on social media or email:

Connecting Veterans and Their Families with Free Online Wellness Programming and Community


BurnAlong Platform Devices - Preview Image

BurnAlong Platform Preview

“BurnAlong understands the importance of bringing mental and physical strength front and center, so that no Veteran places boundaries on themselves. The roles are reversed, we have to fight for them now!” – Lynn Coffland, Founder of Catch A Lift Fund

Tackling head on the physical and mental health challenges facing the more than 18 million veterans in the US, veterans organization Catch A Lift Fund has partnered with leading technology wellness company BurnAlong to provide free online health, wellness, and fitness video content for veterans and their family members.

Catch A Lift Fund helps combat wounded veterans regain their mental and physical health through gym memberships, in home gym equipment, personalized fitness and nutrition programs and a peer support network. By partnering with BurnAlong, Catch A Lift Fund can for the first time provide on-demand video classes and additional social support to veterans, with newly expanded access.

Through Catch A Lift Fund’s expanded partnership with BurnAlong, more than 7,000 veterans and their family members now have free access to 1000’s of online classes from 100s of instructors spanning 45+ health, wellness, and fitness categories for the next 6 months. They can take group classes in live private sessions with family members, friends, or fellow veterans, where they can see and hear each other.

Catch A Lift Fund veteran instructors are also joining BurnAlong to stream their classes for BurnAlong members. One of the first Catch A Lift Fund classes posted on BurnAlong is from trainer Sarah Rudder, a combat wounded veteran who is an adaptive trainer with a certification in Olympic Lifting. Another new class features Jimmie Blockett, an Army Veteran, who posted a class targeting recovery of the upper extremities. Other veterans are posting classes on BurnAlong, like Christine McBride, a Navy veteran who specializes in meditation and yoga for people suffering from PTSD.

“Since the death of my brother, I have been privileged to work with thousands of combat injured veterans through the Catch A Lift Fund. I have witnessed first-hand how fitness, community and mentorship, have proven to be a driving force for our service members in finding a holistic way to heal both mentally and physically, through the grants we have provided.” Lynn Coffland, Founder of Catch A Lift Fund said, “BurnAlong understands the importance of bringing mental and physical strength front and center, so that no Veteran places boundaries on themselves. The roles are reversed, we have to fight for them now!”

“We are so proud to be supporting Veterans and their families, and are eternally grateful for their service to our country,” said Daniel Freedman, CO-CEO of BurnAlong. “Catch A Lift Fund’s work is so valuable, and we’re proud to be supporting them and their mission. We hope companies and individuals join and support Catch A Lift Fund, to support those who we owe so much to.”

Every Catch A Lift Fund member has additional access to four sub-accounts they can provide – for free – to their spouses and family members. They can take live group classes with their families and other veterans wherever they are in the country in order to get the social support that is so valuable for veterans and their families.

Part of the BurnAlong partnership includes a virtual veteran’s community, where veterans from around the country and their families can share their stories, share advice, and take live group classes together. Volunteers from BurnAlong’s corporate wellness accounts can also join this veteran’s community to help show their support for veterans who are on BurnAlong.

—

About Catch A Lift Fund

Want to learn how you can support Catch A Lift Fund’s mission to provide fitness and health support for veterans around the country? Visit https://catchaliftfund.org/ or contact lynn@catchaliftfund.com for more information.

About BurnAlong (http://www.BurnAlong.com):

BurnAlong is an online video health and wellness platform. People can take classes from 100s of instructors across 45 categories, from prenatal to seniors, from cardio and yoga to stress, adaptive workouts, and chronic conditions like arthritis and diabetes. People can take classes alone or live with others where they can see and hear each other for social motivation.

BurnAlong works with leading employers, insurers, municipalities, non-profits, and health systems who provide BurnAlong for their employees, members, and patients. Through the partnership with Catch A Lift Fund, BurnAlong expands its platform to provide personalized health and wellness content and social support to veterans around the country.

Want to learn how you can help provide more Catch A Lift Fund veterans with access to BurnAlong? Contact info@burnalong.com.

Want to bring BurnAlong to your members or employees? Contact info@burnalong.com to learn more.

For press inquiries, contact press@burnalong.com or visit http://www.burnalong.com/press-inquiries.

Share article on social media or email: